Oxidative Stress and Dysfunctional NRF2 Underlie Pachyonychia Congenita Phenotypes

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2016 May 17

PMID 27183391

Citations 28

Authors

Michelle L Kerns

Jill M C Hakim

Rosemary G Lu

Yajuan Guo

Andreas Berroth

Roger L Kaspar

Pierre A Coulombe

Affiliations

Soon will be listed here.

Abstract

Palmoplantar keratoderma (PPK) are debilitating lesions that arise in individuals with pachyonychia congenita (PC) and feature upregulation of danger-associated molecular patterns and skin barrier regulators. The defining features of PC-associated PPK are reproduced in mice null for keratin 16 (Krt16), which is commonly mutated in PC patients. Here, we have shown that PPK onset is preceded by oxidative stress in footpad skin of Krt16-/- mice and correlates with an inability of keratinocytes to sustain nuclear factor erythroid-derived 2 related factor 2-dependent (NRF2-dependent) synthesis of the cellular antioxidant glutathione (GSH). Additionally, examination of plantar skin biopsies from individuals with PC confirmed the presence of high levels of hypophosphorylated NRF2 in lesional tissue. In Krt16-/- mice, genetic ablation of Nrf2 worsened spontaneous skin lesions and accelerated PPK development in footpad skin. Hypoactivity of NRF2 in Krt16-/- footpad skin correlated with decreased levels or activity of upstream NRF2 activators, including PKCδ, receptor for activated C kinase 1 (RACK1), and p21. Topical application of the NRF2 activator sulforaphane to the footpad of Krt16-/- mice prevented the development of PPK and normalized redox balance via regeneration of GSH from existing cellular pools. Together, these findings point to oxidative stress and dysfunctional NRF2 as contributors to PPK pathogenesis, identify K16 as a regulator of NRF2 activation, and suggest that pharmacological activation of NRF2 should be further explored for PC treatment.

Citing Articles

Treatment of palmoplantar keratoderma in a patient with ichthyosis with topical tapinarof.

Robinson S, Kranseler J, Rosmarin D JAAD Case Rep. 2024; 45:66-67.

PMID: 38389856 PMC: 10882012. DOI: 10.1016/j.jdcr.2024.01.017.

Significance of stress keratin expression in normal and diseased epithelia.

Cohen E, Johnson C, Wasikowski R, Billi A, Tsoi L, Kahlenberg J iScience. 2024; 27(2):108805.

PMID: 38299111 PMC: 10828818. DOI: 10.1016/j.isci.2024.108805.

Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis.

Chen Y, Tai Z, Zhu C, Yu Q, Zhu Q, Chen Z Int J Mol Sci. 2024; 25(1).

PMID: 38203230 PMC: 10778864. DOI: 10.3390/ijms25010059.

Role of Phytochemicals in Skin Photoprotection Regulation of Nrf2.

Chaiprasongsuk A, Panich U Front Pharmacol. 2022; 13:823881.

PMID: 35645796 PMC: 9133606. DOI: 10.3389/fphar.2022.823881.

Redox signaling at the crossroads of human health and disease.

Zuo J, Zhang Z, Luo M, Zhou L, Nice E, Zhang W MedComm (2020). 2022; 3(2):e127.

PMID: 35386842 PMC: 8971743. DOI: 10.1002/mco2.127.

References

Omary M, Coulombe P, McLean W . Intermediate filament proteins and their associated diseases. N Engl J Med. 2004; 351(20):2087-100. DOI: 10.1056/NEJMra040319. View

Lessard J, Coulombe P . Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. J Invest Dermatol. 2012; 132(5):1384-91. PMC: 3326191. DOI: 10.1038/jid.2012.6. View

Leachman S, Hickerson R, Schwartz M, Bullough E, Hutcherson S, Boucher K . First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther. 2009; 18(2):442-6. PMC: 2839285. DOI: 10.1038/mt.2009.273. View

Lushchak V . Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012; 2012:736837. PMC: 3303626. DOI: 10.1155/2012/736837. View

Goldberg I, Fruchter D, Meilick A, Schwartz M, Sprecher E . Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol Venereol. 2013; 28(3):279-85. DOI: 10.1111/jdv.12098. View

Coulombe P, Hutton M, Vassar R, Fuchs E . A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J Cell Biol. 1991; 115(6):1661-74. PMC: 2289221. DOI: 10.1083/jcb.115.6.1661. View

Gorrini C, Harris I, Mak T . Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12(12):931-47. DOI: 10.1038/nrd4002. View

Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel J . Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999; 13(1):76-86. PMC: 316370. DOI: 10.1101/gad.13.1.76. View

Kim Y, Coon A, Baker A, Powis G . Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemother Pharmacol. 2010; 68(2):405-13. PMC: 3107346. DOI: 10.1007/s00280-010-1500-0. View

10.

Choi Y, Fuchs E . TGF-beta and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1990; 1(11):791-809. PMC: 361689. DOI: 10.1091/mbc.1.11.791. View

11.

Jia D, Duan F, Peng P, Sun L, Liu X, Wang L . Up-regulation of RACK1 by TGF-β1 promotes hepatic fibrosis in mice. PLoS One. 2013; 8(3):e60115. PMC: 3612079. DOI: 10.1371/journal.pone.0060115. View

12.

Szeverenyi I, Cassidy A, Chung C, Lee B, Common J, Ogg S . The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat. 2007; 29(3):351-60. DOI: 10.1002/humu.20652. View

13.

Hermanto U, Zong C, Li W, Wang L . RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol. 2002; 22(7):2345-65. PMC: 133698. DOI: 10.1128/MCB.22.7.2345-2365.2002. View

14.

Pan X, Hobbs R, Coulombe P . The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr Opin Cell Biol. 2012; 25(1):47-56. PMC: 3578078. DOI: 10.1016/j.ceb.2012.10.018. View

15.

Bernot K, Coulombe P, McGowan K . Keratin 16 expression defines a subset of epithelial cells during skin morphogenesis and the hair cycle. J Invest Dermatol. 2002; 119(5):1137-49. DOI: 10.1046/j.1523-1747.2002.19518.x. View

16.

Smith F, Liao H, Cassidy A, Stewart A, Hamill K, Wood P . The genetic basis of pachyonychia congenita. J Investig Dermatol Symp Proc. 2005; 10(1):21-30. DOI: 10.1111/j.1087-0024.2005.10204.x. View

17.

McGowan K, Coulombe P . The wound repair-associated keratins 6, 16, and 17. Insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture. Subcell Biochem. 1999; 31:173-204. View

18.

Hobbs R, DePianto D, Jacob J, Han M, Chung B, Batazzi A . Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes. Nat Genet. 2015; 47(8):933-8. PMC: 4520766. DOI: 10.1038/ng.3355. View

19.

Hamada T, Tsuruta D, Fukuda S, Ishii N, Teye K, Numata S . How do keratinizing disorders and blistering disorders overlap?. Exp Dermatol. 2012; 22(2):83-7. DOI: 10.1111/exd.12021. View

20.

Yang Y, Dieter M, Chen Y, Shertzer H, Nebert D, Dalton T . Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem. 2002; 277(51):49446-52. DOI: 10.1074/jbc.M209372200. View